メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Medtronic
Cyberonics
St. Jude Medical
BioControl Medical
Leptos Medical
EnteroMedics
Nevro
Nuvectra
地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米(米国、カナダ、メキシコ)
ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
アジア太平洋(中国、日本、韓国、インド、東南アジア)
南アメリカ(ブラジル、アルゼンチン、コロンビアなど)
中東およびアフリカ(サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ)
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Obesity Treating Neuromodulation System Market Size Growth Rate by Type (2020-2025)
1.3.2 Vagus Nerve Stimulator
1.3.3 Splanchnic Nerve Stimulator
1.3.4 Deep Brain Stimulator
1.3.5 Spinal Cord Stimulator
1.3.6 Autonomous Nerve Stimulator
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Obesity Treating Neuromodulation System Market Share by Application (2020-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Ambulatory Surgical Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Obesity Treating Neuromodulation System Production Value 2015-2025
2.1.2 Global Obesity Treating Neuromodulation System Production 2015-2025
2.1.3 Global Obesity Treating Neuromodulation System Capacity 2015-2025
2.1.4 Global Obesity Treating Neuromodulation System Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Obesity Treating Neuromodulation System Market Size CAGR of Key Regions
2.2.2 Global Obesity Treating Neuromodulation System Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Obesity Treating Neuromodulation System Capacity by Manufacturers
3.1.2 Global Obesity Treating Neuromodulation System Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Obesity Treating Neuromodulation System Revenue by Manufacturers (2015-2019)
3.2.2 Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Obesity Treating Neuromodulation System Market Concentration Ratio (CR5 and HHI)
3.3 Obesity Treating Neuromodulation System Price by Manufacturers
3.4 Key Manufacturers Obesity Treating Neuromodulation System Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Obesity Treating Neuromodulation System Market
3.6 Key Manufacturers Obesity Treating Neuromodulation System Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Vagus Nerve Stimulator Production and Production Value (2015-2019)
4.1.2 Splanchnic Nerve Stimulator Production and Production Value (2015-2019)
4.1.3 Deep Brain Stimulator Production and Production Value (2015-2019)
4.1.4 Spinal Cord Stimulator Production and Production Value (2015-2019)
4.1.5 Autonomous Nerve Stimulator Production and Production Value (2015-2019)
4.1.6 Others Production and Production Value (2015-2019)
4.2 Global Obesity Treating Neuromodulation System Production Market Share by Type
4.3 Global Obesity Treating Neuromodulation System Production Value Market Share by Type
4.4 Obesity Treating Neuromodulation System Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Obesity Treating Neuromodulation System Consumption by Application
6 Production by Regions
6.1 Global Obesity Treating Neuromodulation System Production (History Data) by Regions 2015-2019
6.2 Global Obesity Treating Neuromodulation System Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Obesity Treating Neuromodulation System Production Growth Rate 2015-2019
6.3.2 United States Obesity Treating Neuromodulation System Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Obesity Treating Neuromodulation System Import & Export
6.4 European Union
6.4.1 European Union Obesity Treating Neuromodulation System Production Growth Rate 2015-2019
6.4.2 European Union Obesity Treating Neuromodulation System Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Obesity Treating Neuromodulation System Import & Export
6.5 China
6.5.1 China Obesity Treating Neuromodulation System Production Growth Rate 2015-2019
6.5.2 China Obesity Treating Neuromodulation System Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Obesity Treating Neuromodulation System Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Obesity Treating Neuromodulation System Consumption by Regions
7.1 Global Obesity Treating Neuromodulation System Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Obesity Treating Neuromodulation System Consumption by Type
7.2.2 United States Obesity Treating Neuromodulation System Consumption by Application
7.3 European Union
7.3.1 European Union Obesity Treating Neuromodulation System Consumption by Type
7.3.2 European Union Obesity Treating Neuromodulation System Consumption by Application
7.4 China
7.4.1 China Obesity Treating Neuromodulation System Consumption by Type
7.4.2 China Obesity Treating Neuromodulation System Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Obesity Treating Neuromodulation System Consumption by Type
7.5.2 Rest of World Obesity Treating Neuromodulation System Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Medtronic
8.1.1 Medtronic Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Obesity Treating Neuromodulation System
8.1.4 Obesity Treating Neuromodulation System Product Introduction
8.1.5 Medtronic Recent Development
8.2 Cyberonics
8.2.1 Cyberonics Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Obesity Treating Neuromodulation System
8.2.4 Obesity Treating Neuromodulation System Product Introduction
8.2.5 Cyberonics Recent Development
8.3 St. Jude Medical
8.3.1 St. Jude Medical Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Obesity Treating Neuromodulation System
8.3.4 Obesity Treating Neuromodulation System Product Introduction
8.3.5 St. Jude Medical Recent Development
8.4 BioControl Medical
8.4.1 BioControl Medical Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Obesity Treating Neuromodulation System
8.4.4 Obesity Treating Neuromodulation System Product Introduction
8.4.5 BioControl Medical Recent Development
8.5 Leptos Medical
8.5.1 Leptos Medical Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Obesity Treating Neuromodulation System
8.5.4 Obesity Treating Neuromodulation System Product Introduction
8.5.5 Leptos Medical Recent Development
8.6 EnteroMedics
8.6.1 EnteroMedics Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Obesity Treating Neuromodulation System
8.6.4 Obesity Treating Neuromodulation System Product Introduction
8.6.5 EnteroMedics Recent Development
8.7 Nevro
8.7.1 Nevro Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Obesity Treating Neuromodulation System
8.7.4 Obesity Treating Neuromodulation System Product Introduction
8.7.5 Nevro Recent Development
8.8 Nuvectra
8.8.1 Nuvectra Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Obesity Treating Neuromodulation System
8.8.4 Obesity Treating Neuromodulation System Product Introduction
8.8.5 Nuvectra Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Obesity Treating Neuromodulation System Capacity, Production Forecast 2020-2025
9.1.2 Global Obesity Treating Neuromodulation System Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Obesity Treating Neuromodulation System Production and Value Forecast by Regions 2020-2025
9.2.2 Global Obesity Treating Neuromodulation System Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Obesity Treating Neuromodulation System Production Forecast by Type
9.7.2 Global Obesity Treating Neuromodulation System Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Obesity Treating Neuromodulation System Sales Channels
10.2.2 Obesity Treating Neuromodulation System Distributors
10.3 Obesity Treating Neuromodulation System Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter\'s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer